Quest Diagnostics Incorporated DGX
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 9.13% | 9.87% | 11.03% | 11.78% | 13.74% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.13% | 9.87% | 11.03% | 11.78% | 13.74% |
| Cost of Revenue | 9.61% | 9.92% | 10.70% | 11.52% | 12.94% |
| Gross Profit | 8.18% | 9.75% | 11.69% | 12.30% | 15.37% |
| SG&A Expenses | 7.12% | 9.55% | 11.55% | 11.27% | 12.85% |
| Depreciation & Amortization | -3.25% | 2.72% | 10.95% | 21.26% | 31.62% |
| Other Operating Expenses | -400.00% | 0.00% | -250.00% | -200.00% | 150.00% |
| Total Operating Expenses | 8.85% | 9.73% | 10.81% | 11.59% | 13.23% |
| Operating Income | 10.82% | 10.66% | 12.30% | 12.91% | 16.86% |
| Income Before Tax | 14.69% | 10.83% | 15.65% | 13.90% | 16.92% |
| Income Tax Expenses | 13.62% | 10.73% | 23.68% | 15.02% | 22.86% |
| Earnings from Continuing Operations | 15.01% | 10.86% | 13.40% | 13.57% | 15.28% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 10.53% | 5.56% | 0.00% | -8.00% | -16.33% |
| Net Income | 16.51% | 11.79% | 14.16% | 13.89% | 15.22% |
| EBIT | 10.82% | 10.66% | 12.30% | 12.91% | 16.86% |
| EBITDA | 9.16% | 9.65% | 12.12% | 13.61% | 17.65% |
| EPS Basic | 17.93% | 12.51% | 14.34% | 13.81% | 14.87% |
| Normalized Basic EPS | 16.06% | 13.93% | 13.82% | 12.05% | 11.37% |
| EPS Diluted | 17.63% | 12.62% | 14.20% | 13.57% | 15.74% |
| Normalized Diluted EPS | 16.00% | 14.16% | 14.06% | 12.08% | 10.92% |
| Average Basic Shares Outstanding | -0.90% | -0.45% | 0.00% | 0.22% | 0.00% |
| Average Diluted Shares Outstanding | -0.88% | -0.66% | -0.22% | 0.22% | 0.44% |
| Dividend Per Share | 7.30% | 7.10% | 6.89% | 6.67% | 6.42% |
| Payout Ratio | -0.09% | -0.05% | -0.07% | -0.06% | -0.08% |